glp 1 adalah What is GLP-1 & Does it Affect Weight & Cognition? GLP-1 Genetics: How Genes Affect
Description
According to the World Health Organization, obesity prevalence has nearly tripled since 1975, and it is associated with increased risks of developing chronic diseases such as type 2 diabetes, cardiovascular disease, and certain types of cancer

List of Prominent Players in the GLP-1 Market: AstraZeneca Biolingus Boehringer Ingelheim D&D Pharmatech Eli Lilly Gmax Biopharm Hanmi Pharmaceutical Innogen Novo Nordisk PegBio Pfizer QL Biopharma Roche Sanofi Sciwind Biosciences Tonghua Dongbao Pharmaceutical Viking Therapeutics Vivani vTv Therapeutic Expert Knowledge, Just a Click Away: Market Dynamics Drivers: The global surge in type 2 diabetes and obesity is a primary catalyst for the growth of the GLP-1 receptor agonist market

This natural physiological response occurs because the body reduces total tissue maintenance demands as overall mass decreasesa process not unique to GLP-1 medications

Long-Term Use : Long-term use of GLP-1 medications has been shown to sustain weight loss and glycemic control
Narrative reviews discuss that high pricing, insurance exclusions, and concerns about the appropriateness of prescribing may reinforce existing disparities and stigma [89]
